Global Biomaterials Market, By Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramics, and Natural Biomaterials), Application (Cardiovascular, Orthopaedic, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Neurological/Central Nervous System Applications, and Other Applications) – Industry Trends and Forecast to 2031.
Biomaterials Market Analysis and Size
In the realm of drug delivery, biomaterials serve as the backbone for innovative systems such as nanoparticles, microspheres, and hydrogels. These platforms encapsulate therapeutic agents, shielding them from degradation and enabling precise delivery to target sites within the body. Nanoparticles, typically on the nanometer scale, offer enhanced cellular uptake and prolonged circulation times. Microspheres provide controlled release kinetics, ensuring sustained therapeutic levels over extended periods. Hydrogels, with their tunable properties, offer spatial and temporal control over drug release, catering to specific physiological conditions.
The global biomaterials market size was valued at USD 176.73 Billion in 2023 and is projected to reach USD 503.42 Billion by 2031, with a CAGR of 13.98% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024-2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramics, and Natural Biomaterials), Application (Cardiovascular, Orthopaedic, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Neurological/Central Nervous System Applications, and Other Applications)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa , Brazil, Argentina and Rest of South America
|
|
Market Players Covered
|
Johnson & Johnson. (U.S.), Stryker. (U.S.), CoorsTek Inc.(U.S.), Zimmer Biomet (U.S.), Corbionollagen Matrix, Inc. (U.S.), CRS Holdings, LLC. (U.S.), Berkeley Advanced Biomaterials (U.S.), Covalon Technologies Ltd. (Canada), Medtronic plc (Ireland), BASF SE (Germany), Evonik Industries AG (Germany ), and Invibio Ltd. (U.K.)
|
|
Market Opportunities
|
|
Market Definition
Biomaterials are substances engineered to interact with biological systems for medical purposes, ranging from implants and prosthetics to drug delivery systems. They are designed to be compatible with living tissues, promoting healing and regeneration while often possessing specific mechanical, chemical, and biological properties. Biomaterials play a crucial role in various medical applications, facilitating advancements in healthcare and improving patient outcomes.
Hair Transplant Market Dynamics
Drivers
- Growing Technological Advancements
Breakthroughs in material science, nanotechnology, and biotechnology continually enhance the properties and functionalities of biomaterials, unlocking new applications and improving existing ones. These advancements enable the development of biomaterials with tailored properties such as biocompatibility, mechanical strength, and controlled degradation, meeting the diverse needs of medical, pharmaceutical, and other industries. Advancements in manufacturing processes, such as additive manufacturing and biofabrication, enable the production of complex biomaterial structures with precise control at the micro and nanoscale, driving the market forward.
- Rising Elderly Population
The growing aging population is more prone to age-related health issues such as osteoarthritis, cardiovascular diseases, and dental problems, necessitating the use of biomaterials in medical implants, prosthetics, and tissue engineering solutions. Biomaterials play a crucial role in restoring function and quality of life for elderly individuals by providing durable and biocompatible replacements for degenerated tissues and organs. The demand for biomaterials is amplified by the desire for active and independent lifestyles among the elderly, driving innovation in materials science and biomedical engineering to meet the unique needs of this demographic.
Opportunities
- Increasing Supportive Government Policies
Policies such as research grants, tax incentives, and regulatory frameworks aimed at promoting innovation in healthcare and biotechnology stimulate investment in biomaterials research and development. Additionally, government initiatives focused on healthcare infrastructure development and public health programs create demand for advanced biomaterials used in medical devices, implants, and regenerative medicine. Supportive policies accelerate the translation of biomaterials research into tangible products and therapies by fostering collaboration between academia, industry, and regulatory bodies that ultimately drives market expansion and improving patient outcomes.
- Increasing Demand for Minimally Invasive Procedures
Patients seek less invasive treatment options through which there's a growing need for biomaterials that enable the development of advanced medical devices and surgical techniques. Biomaterials play a pivotal role in these procedures by providing materials for implants, instruments, and surgical tools that are compatible with the body and promote healing. Moreover, biomaterials facilitate the creation of specialized coatings and drug delivery systems used in minimally invasive interventions, enhancing their efficacy and safety. This trend towards minimally invasive procedures drives innovation in biomaterials, spurring research and development efforts to meet the evolving needs of patients and healthcare providers.
Restraints/Challenges
- High Development Costs
The research and development process for biomaterials involves substantial investment in specialized equipment, materials, and skilled personnel. In addition, conducting preclinical and clinical trials to ensure safety and efficacy further adds to the expense. These high costs can deter smaller companies and startups from entering the market, limiting competition and innovation. Moreover, the lengthy development timeline coupled with uncertain regulatory pathways can prolong the time to market, increasing overall expenses and hindering profitability.
- Growing Competition from Alternative Therapies
Traditional treatment modalities such as pharmaceuticals, surgeries, and non-invasive procedures offer established alternatives to biomaterial-based interventions. Patients or healthcare providers may prefer these alternatives due to factors such as familiarity, perceived efficacy, or cost-effectiveness. Biomaterials face stiff competition in the healthcare landscape, requiring continuous innovation and differentiation to maintain market relevance and capture market share.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In October 2023, Evonik launched VESTAKEEP iC4612 3DF and iC4620 3DF, pioneering carbon-fiber-reinforced PEEK filaments for 3D-printed medical implants. These filaments offer a unique combination of strength, ductility, and adaptability, marking a significant leap in personalized medical treatments and underlining Evonik's dedication to innovation in patient care
- In April 2023, Novo Nordisk forged a strategic collaboration with Aspect Biosystems to develop bioprinted tissue therapeutics targeting obesity and diabetes. This collaboration leverages Aspect Biosystems' expertise in bioprinting biomaterials, aligning with Novo Nordisk's commitment to advancing cutting-edge treatments for metabolic disorders
- In March 2023, Invibio Biomaterial Solutions launched Peek-Optima Am filament, a polyetheretherketone polymer-based material designed for the 3D printing of medical devices. This launch expands Invibio's portfolio of innovative biomaterials, offering enhanced manufacturing capabilities for medical applications and reinforcing its position as a leader in the biomaterials industry
- In January 2023, Zimmer Biomet Holdings, Inc. announced its acquisition plans for Embody, Inc., with an initial investment of USD 155 million, potentially increasing to USD 275 million based on future milestones. This strategic move aims to bolster Zimmer Biomet's sports medicine portfolio, particularly focusing on advanced soft tissue healing solutions, reflecting the company's commitment to expanding its product offerings through strategic acquisitions
Biomaterials Market Scope
The market is segmented on the basis of type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Metallic Biomaterials
- Stainless Steel
- Titanium and Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
- Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Polyvinylchloride
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
- Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
- Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk
Application
- Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
- Orthopaedic
- Joint Replacement
- Knee Replacement
- Hip Replacement
- Shoulder Replacement
- Others
- Ophthalmology
- Contact Lenses
- Intraocular Lenses
- Functional Replacement of Ocular Tissues
- Synthetic Corneas
- Others
- Dental
- Dental Implants
- Dental Bone Grafts and Substitutes
- Dental Membranes
- Tissue Regeneration
- Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
- Wound Healing
- Wound Closure Devices
- Sutures
- Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
- Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
- Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
- Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications
Biomaterials Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, type, and application, as referenced above.
The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America is expected to dominate the market is fueled by a combination of favorable government policies supporting research and development initiatives and stringent regulatory frameworks that encourage innovation. Additionally, the region benefits from the presence of numerous major market players, fostering a robust ecosystem for collaboration and investment. This conducive environment has propelled North America to the forefront of biomaterials innovation, driving advancements in medical devices, tissue engineering, and regenerative medicine.
Asia-Pacific is expected to have significant growth due to strategic initiatives undertaken by local stakeholders to bolster their market presence both domestically and internationally. These initiatives encompass various measures such as investment in infrastructure, technological advancements, and fostering partnerships to enhance competitiveness. As a result, the region is expected to experience robust economic expansion, driving growth in diverse sectors and solidifying its position as a key player in the market landscape.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Biomaterials Market Analysis
The market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the market are:
- Johnson & Johnson. (U.S.)
- Stryker. (U.S.)
- CoorsTek Inc.(U.S.)
- Zimmer Biomet (U.S.)
- Corbionollagen Matrix, Inc. (U.S.)
- CRS Holdings, LLC. (U.S.)
- Berkeley Advanced Biomaterials (U.S.)
- Covalon Technologies Ltd. (Canada)
- Medtronic plc (Ireland)
- BASF SE (Germany)
- Evonik Industries AG (Germany )
- Invibio Ltd. (U.K.)
SKU-